Alima Khan

Alima works alongside Maryna to discover novel peptide binders through phage display. She gained expertise in oncology and therapeutics at Triumvira Immunologics, leveraging her MSc from the University of Toronto, where she explored anti-CRISPR mechanisms on the CRISPR-Cas system.